Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PARASTOP - Paracetamol With Strong Opioids. A Randomized, Double-blind, Parallel-group Non-inferiority Phase III Withdrawal Trial of Paracetamol Versus Placebo in Conjunction With Opioids for Moderate to Severe Cancer-related Pain

NCT05051735 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT05051735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05051735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PARASTOP - Paracetamol With Strong Opioids. A Randomized, Double-blind, Parallel-group Non-inferiority Phase III Withdrawal Trial of Paracetamol Versus Placebo in Conjunction With Opioids for Moderate to Severe Cancer-related Pain
Lead sponsor
Oslo University Hospital
Phase
Phase 3
Overall status
Completed
Start date
October 20, 2021
Completion date
February 18, 2026
Enrollment
204 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cancer pain